Matches in Wikidata for { <http://www.wikidata.org/entity/Q95309291> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q95309291 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q95309291 description "scientific article published on 19 May 2020" @default.
- Q95309291 description "wetenschappelijk artikel" @default.
- Q95309291 description "наукова стаття, опублікована 19 травня 2020" @default.
- Q95309291 name "Conversion from tacrolimus to sirolimus as a treatment modality in de novo allergies and immune-mediated disorders in pediatric liver transplant recipients" @default.
- Q95309291 name "Conversion from tacrolimus to sirolimus as a treatment modality in de novo allergies and immune-mediated disorders in pediatric liver transplant recipients" @default.
- Q95309291 type Item @default.
- Q95309291 label "Conversion from tacrolimus to sirolimus as a treatment modality in de novo allergies and immune-mediated disorders in pediatric liver transplant recipients" @default.
- Q95309291 label "Conversion from tacrolimus to sirolimus as a treatment modality in de novo allergies and immune-mediated disorders in pediatric liver transplant recipients" @default.
- Q95309291 prefLabel "Conversion from tacrolimus to sirolimus as a treatment modality in de novo allergies and immune-mediated disorders in pediatric liver transplant recipients" @default.
- Q95309291 prefLabel "Conversion from tacrolimus to sirolimus as a treatment modality in de novo allergies and immune-mediated disorders in pediatric liver transplant recipients" @default.
- Q95309291 P1433 Q95309291-4D2620ED-41F1-499B-BB2E-CD0B6496FAC3 @default.
- Q95309291 P1476 Q95309291-7163F043-E6D5-4369-9273-073EFCA395E9 @default.
- Q95309291 P2093 Q95309291-0957E1CF-D083-4EF7-A5B3-ED350F5DB823 @default.
- Q95309291 P2093 Q95309291-31CA5336-DEA2-4684-8B68-C7FB8D0E82A3 @default.
- Q95309291 P2093 Q95309291-A1C63F15-9382-46B6-9986-E9A9E5A7A329 @default.
- Q95309291 P2093 Q95309291-B58D6EC9-AECA-413A-87FA-574C1607BE25 @default.
- Q95309291 P304 Q95309291-82C5624D-C947-47EA-A903-92F433B62FC1 @default.
- Q95309291 P31 Q95309291-4498AF76-056E-45E4-9FEF-7957C65541F8 @default.
- Q95309291 P356 Q95309291-F7AAFA63-7594-49F9-A57F-FAC8C0C3CF8D @default.
- Q95309291 P50 Q95309291-7ECED932-BAF9-44A9-9C5A-6D8F7811D924 @default.
- Q95309291 P50 Q95309291-8B13614E-7719-4EC5-9E50-29BF69C75B50 @default.
- Q95309291 P50 Q95309291-AA1C100D-0DA0-48D2-9383-F04B7BBD8684 @default.
- Q95309291 P577 Q95309291-A40290CC-7EA8-4FC1-8356-8FCC0B7F986D @default.
- Q95309291 P698 Q95309291-88919714-94D9-478C-972E-DA2A44CA7C7F @default.
- Q95309291 P921 Q95309291-18BC525C-5E54-48DA-B6EA-1C6C175DD119 @default.
- Q95309291 P356 PETR.13737 @default.
- Q95309291 P698 32428390 @default.
- Q95309291 P1433 Q7159217 @default.
- Q95309291 P1476 "Conversion from tacrolimus to sirolimus as a treatment modality in de novo allergies and immune-mediated disorders in pediatric liver transplant recipients" @default.
- Q95309291 P2093 "Alisha Jamal" @default.
- Q95309291 P2093 "Carolina Jimenez-Rivera" @default.
- Q95309291 P2093 "Eyal Grunebaum" @default.
- Q95309291 P2093 "Yael Mozer-Glassberg" @default.
- Q95309291 P304 "e13737" @default.
- Q95309291 P31 Q13442814 @default.
- Q95309291 P356 "10.1111/PETR.13737" @default.
- Q95309291 P50 Q59166989 @default.
- Q95309291 P50 Q88712203 @default.
- Q95309291 P50 Q93177135 @default.
- Q95309291 P577 "2020-05-19T00:00:00Z" @default.
- Q95309291 P698 "32428390" @default.
- Q95309291 P921 Q32089 @default.